The Oxford/AstraZeneca (Vaxrevia) vaccine, indicated in adults, was linked to a rare but serious side effect called thrombosis with thrombocytopenia syndrome (TTS). On 27 March 2024, the European Com…
Vaxrevia Data Release
Hold onto your shirt. MHRA have answered the VaxRevia questions:
